Varian Medical Systems has received Food and Drug Administration 510(k) clearance for a new suite of features on its On-Board Imager system for the Clinac and Trilogy medical linear accelerators. The new features allow On-Board Imager to synchronize image acquisition with a patient's respiratory cycle and automate "marker matching" for more precise tumor targeting, according to the Palo Alto, CA-based vendor.
An automated tumor marker-detection feature automatically positions a patient for treatment by detecting and imaging gold seeds or other fiducial markers implanted in a tumor, Varian said. The On-Board Imager can also now perform monitoring and gating for tumor motion, according to the vendor.
By AuntMinnie.com staff writers
August 9, 2004
Related Reading
Varian gets OK for dose calculator, August 3, 2004
Varian posts robust Q3, July 30, 2004
Varian adds to Eclipse, July 23, 2004
Varian expects strong Q3, July 15, 2004
Varian, Proxima team up for partial breast irradiation, July 7, 2004
Copyright © 2004 AuntMinnie.com
